Dr. Roger I. Glass Named Director of Fogarty International Center
National Institutes of Health (NIH) Director Elias A. Zerhouni, MD, recently named Dr. Roger I. Glass the new director of the Fogarty International Center (FIC) and associate director of the NIH for international programs. The FIC works to reduce disparities in global health through the promotion and support of scientific research and training on an international level. Additionally, the FIC serves as a leader in the formulation and implementation of biomedical research and policy. Dr. Glass said that he is deeply honored by his appointment as the new leader of the FIC, where he will oversee an annual budget of more than $60 million. Dr. Glass described the FIC as especially significant owing to the role of the Center in establishing and developing programs to identify and meet emerging global health challenges. Director Zerhouni said that Dr. Glass's expertise will help advance the FIC's “quest to eliminate health disparities worldwide.” Dr. Glass currently serves as the chief of the Viral Gastroenteritis Section at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. Dr. Glass graduated from Harvard College in 1967, and in the same year, he received a Fullbright Fellowship to study at the University of Buenos Aires. In 1972, Dr. Glass earned his MD from Harvard Medical School and his MPH from the Harvard School of Public Health. After receiving his doctorate from the University of Göteborg, Sweden, in 1983, Dr. Glass joined the Laboratory of Infectious Diseases at the NIH. He joined the CDC in 1986 as chief of the Viral Gastroenteritis Unit at the National Center for Infectious Diseases. His research interests include the biology and prevention of gastroenteritis. Dr. Glass has conducted field studies in numerous locations, including India, Bangladesh, Brazil, Mexico, Israel, Russia, Vietnam, and China, and has received multiple awards in recognition of his work, such as the Secretary's Award for Distinguished Service (from the Department of Health and Human Services), the Outstanding Unit Citation from the National Center for Infectious Diseases, the Outstanding Service Medal from the US Public Health Service, and a Commendation from the US Public Health Service. Dr. Glass is a member of the US National Academy of Science's Institute of Medicine, American Academy of Microbiology, American Society of Microbiology, American Association for the Advancement of Science, American Society of Virology, and American Epidemiological Society. Dr. Glass is a fellow in the Infectious Disease Society and the American College of Epidemiology and has coauthored more than 400 research papers and chapters. Dr. Glass joins the NIH in May.
Jonathan A. Epstein, MD, Named Chair of the University of Pennsylvania School of Medicine, Department of Cell and Developmental Biology
Dr. Jonathan A. Epstein has been named the new chair of the Department of Cell and Developmental Biology at the University of Pennsylvania School of Medicine. Dr. Arthur Rubenstein, executive vice president of the University of Pennsylvania for the Health System and dean of the School of Medicine, expressed his confidence in Dr. Epstein's qualifications, noting Dr. Epstein's extensive expertise in the investigation of the mechanisms of cardiovascular development. Dr. Epstein is a professor of medicine in the University of Pennsylvania School of Medicine, with a secondary appointment as a professor of cell and developmental biology. Dr. Epstein received his BA and MD from Harvard University and completed his residency and cardiology fellowship training at Brigham and Women's Hospital. Dr. Epstein came to the University of Pennsylvania in 1996 as an assistant professor. He has held the William Wickoff Smith Chair in Cardiovascular Research since 2004. In 2005, he was named scientific director of the University of Pennsylvania Cardiovascular Institute. Dr. Epstein has been involved in investigations in a number of multidisciplinary centers and institutes, including the Abramson Cancer Center, Pennsylvania Muscle Institute, Graduate Group in Cell and Molecular Biology, and Institute for Medicine and Engineering. Dr. Epstein has received numerous awards for his work, including the Outstanding Investigator Award from the American Federation for Medical Research, the Clinician Investigator Development Award from the National Heart, Lung, and Blood Institute, and the McCabe Fellow Award for research that bridges clinical and basic sciences. In addition, Dr. Epstein headed the Clinical Investigator Pathway in the Department of Medicine's residency program from 2001 to 2005. During his time at the University of Pennsylvania, Dr. Epstein has published more than 75 scientific articles.
A. Oliver Sartor, MD, Accepts Position with Dana-Farber
Nationally renowned prostate cancer specialist Dr. A. Oliver Sartor recently joined the Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology. Dr. Sartor is also associate professor of medicine at Harvard Medical School. Director of the Lank Center for Genitourinary Oncology Dr. Philip Kantoff noted that Dr. Sartor brings with him an immense amount of clinical expertise and clinical research experience, as well as a deep appreciation of ethnic disparities in health care. Most recently, Dr. Sartor served at the Louisiana State University Health Sciences Center in New Orleans as the director of the Stanley S. Scott Cancer Center, as well as co-director of the Louisiana Cancer Research Consortium, which focuses on enhancing cancer research in Louisiana. Dr. Sartor received his medical degree from Tulane University and completed a fellowship with the National Cancer Institute. Dr. Sartor's clinical and scientific interests have focused on advanced prostate cancer, and his research has focused on novel therapies for this disease. Dr. Sartor has authored over 100 scientific papers, and he serves as editor-in-chief of the peer-reviewed journal Clinical Genitourinary Cancer. Dr. Sartor is board certified in internal medicine and medical oncology and is a member of numerous professional societies, such as the American Society of Clinical Oncology, American Association for Cancer Research, American Urological Association, and Society of Urologic Oncology. Dr. Sartor said that he is privileged to join Dana-Farber, and he expressed his excitement about working with his new colleagues toward developing novel and more successful prostate cancer treatments.
Dean of University of Vermont College of Medicine, John N. Evans, to Step Down
John N. Evans, PhD, sixteenth dean of the University of Vermont College of Medicine, recently announced his plans to resign his position on June 30. Dr. Evans will take a 1-year administrative leave and will teach physiology on his return in 2007. Dr. Evans came to the University of Vermont College of Medicine in 1976. He served as executive dean of the College of Medicine and as senior advisor to the dean before taking over as dean in January of 2004 following the death of then dean Dr. Joseph Warshaw. During Evans's time in the dean's office, research funding for the College of Medicine more than tripled to $87.1 million in 2005. Evans was also instrumental in the initiation and implementation of a redesign of the medical curriculum that was undertaken in 2003. Evans aided the formation of Fletcher Allan Health Care and oversaw the medical sciences campus during the construction of the Health Sciences Research Facility and Medical Education Center. A national search for a replacement for Dr. Evans will begin immediately, and an interim dean will be named to serve until a replacement has been found. Dr. Evans received the Alpha Omega Alpha Honor Society Award in 2000. Additionally, in recognition of his exceptional leadership, foresight, and achievements in bettering public health, the Vermont Medical Society honored Evans with the Founders Award. Evans is a member of the Board of Trustees of Fletcher Allen Health Care, the College of Medicine's partner in Vermont's academic health center.
Dr. Lee Goldman to Join Columbia University
Lee Goldman, MD, MPH, was recently named the new executive vice president for health and biomedical services at Columbia University Medical Center, dean of the Faculties of Health Sciences and Medicine at Columbia's College of Physicians and Surgeons, and professor of epidemiology in Columbia's Mailman School of Public Health. In his new position at Columbia, Dr. Goldman will lead a medical center with an annual operating budget of $1.2 billion and $628 million in sponsored research grants from the National Institutes of Health and individual foundations. Most recently, Dr. Goldman served as the chair of the University of California, San Francisco (UCSF) Department of Medicine, Julius R. Krevans Distinguished Professor, and associate dean for clinical affairs at the UCSF School of Medicine. During Dr. Goldman's time as chair of the Department of Medicine, the faculty has grown from around 325 to 550, and National Institutes of Health funding for the department has tripled. Additionally, the UCSF Department of Medicine was recently ranked second among all medical schools in the United States for internal medicine by the US News and World Report. Dr. Goldman earned his undergraduate and medical degrees from Yale University. Dr. Goldman also received his MPH from Yale University. He completed his internship and residency at UCSF and at Massachusetts General Hospital and subsequently a clinical fellowship in cardiology at Yale University School of Medicine. Dr. Goldman served as a member of the faculty of UCSF since 1995. Before his tenure at UCSF, Dr. Goldman was a faculty member at Harvard since 1978, where he served as a professor of medicine at Harvard Medical School and a professor of epidemiology at the Harvard School of Public Health. Additionally, Dr. Goldman served as vice chair of the Department of Medicine and as chief medical officer at Brigham and Women's Hospital. Dr. Goldman is an innovator in the use of statistical analysis in key areas of clinical medicine. He has developed novel predictive models widely used by clinical investigators and practicing physicians, including the Goldman index for assessing cardiac risk involved in noncardiac surgeries and the Goldman criteria to determine which patients with chest pain require hospitalization. Dr. Goldman is a member of the American Society for Clinical Investigation and the Institute of Medicine of the National Academy of Sciences. Dr. Goldman is also a fellow of the American Association for the Advancement of Science and current president of the Association of Professors of Medicine. He is the former president of the Association of American Physicians and the Society of General Internal Medicine, as well as former director of the American Board of Internal Medicine. He is a past recipient of the Glaser Award, the Society of General Internal Medicine's highest honor, and the Blake Award from the Association of American Physicians. Dr. Goldman is the lead editor of the Cecil Textbook of Medicine and co-editor of Hospital Medicine and Primary Cardiology. He is a former editor of The American Journal of Medicine. Dr. Goldman has published over 400 articles, including more than 20 first- or senior-authored articles in The New England Journal of Medicine. Columbia University President Lee C. Bollinger expressed his excitement with the appointment of Dr. Goldman, citing specifically Dr. Goldman's work in synthesizing high-quality medical care, innovative research, commitment to the broader community, and essential management abilities. Dr. Goldman will assume his post at Columbia in late June.
Dr. Joel S. Levine Named Chair-Elect of the American College of Physicians' Board of Regents
Joel S. Levine, MD, FACP, was recently named chair-elect of the Board of regents of the American College of Physicians (ACP), the largest medical specialty organization and second-largest physician group in the United States. Founded in 1915, the ACP serves the interests of more than 119,000 physicians, residents, fellows, and medical school students, with the mission of enhancing the quality, effectiveness, and accessibility of the health care delivered to patients. Dr. Levine said that he is honored by his election to the ACP and that he will work hard to further the ACP's mission to promote health care excellence. Dr. Levine graduated from the State University of New York Downstate Medical Center and received his medical degree in 1971. Dr. Levine completed his internal medicine residency training at Tufts New England Medical Center and a fellowship in gastroenterology at the University of Colorado School of Medicine. Dr. Levine, who has been a fellow of the American College of Physicians since 1982, is board certified in internal medicine and gastroenterology. He has held a variety of positions within the ACP, including the ACP's Colorado governor from 1997 to 2001, member of the ACP's Board of Regents, chair of the group's membership committee, and member of the group's Marketing and Communications, Health and Public Policy, and Awards committees. Dr. Levine is also a fellow of the American Gastroenterological Association, serving as chair of the Association's Public Policy Committee and member of its governing board's Executive Committee from 1996 to 2000. Most recently, Dr. Levine served as a professor in the University of Colorado School of Medicine's Division of Gastroenterology and senior associate dean for clinical affairs at the University of Colorado School of Medicine. After a 1-year term as chair-elect, Dr. Levine will take office as chair of the Board of Regents of the ACP at the College's annual session in San Diego next year.
Dr. Judith Swain to Leave University of California, San Diego; Will Direct Clinical Science Institute in Singapore
Judith Swain, MD, recently announced that she will resign her positions at the University of California, San Diego (UCSD), as professor of medicine, dean for translational medicine, and founding director of the UCSD School of Medicine's College of Integrated Life Sciences (COILS) to assume the position as the founding executive director of the proposed Singapore Institute for Clinical Sciences of the Biomedical Research Council (BMRC) of Singapore's Agency for Science, Technology and Research (A*STAR). The BMRC focuses on clinical and translational research, joining basic biomedical research and patient care. In addition to her appointment with the BMRC, Dr. Swain has also been appointed Lien Ying Chow Professor of Medicine at the National University of Singapore. Before coming to UCSD in 2005, Dr. Swain previously served as Arthur Bloomfield Professor and chair of the Department of Medicine at Stanford University. She also previously held faculty positions at the University of Pennsylvania, serving as the Herbert C. Rorer Professor of Medical Sciences, professor of genetics, and director of cardiovascular medicine. UCSD Chancellor Marye Anne Fox said that UCSD has benefited tremendously from Dr. Swain's experience and foresight and that Dr. Swain has helped create an enduring structure for multidisciplinary research and translational medicine at UCSD. An internationally renowned researcher and scholar, Dr. Swain has devoted her career to bridging the gap between basic research and clinical medicine and to the development and support of physician-scientists. Dr. Swain graduated from the UCSD School of Medicine in 1974 and since has served in numerous national and international leadership positions. Dr. Swain served as president of the American Society for Clinical Investigation and as a member on the councils of the National Heart, Lung, and Blood Institute and the National Center for Research Resources. Dr. Swain is a member of the Institute of Medicine of the National Academies of Sciences, the Association of American Physicians, and the American Society for Clinical Investigation. In her new position, Dr. Swain will seek to develop research connections between agencies and university research centers in Singapore. Additionally, she will help strengthen ties between Singapore and international partners. Dr. Swain's husband, Edward W. Holmes, vice chancellor for health sciences at UCSD, has also announced his intention to leave UCSD to accept appointments with A*STAR and the National University of Singapore.
William L. Henrich, MD, MACP, New Dean of University of Texas Health Science Center at San Antonio Medical School
Dr. William L. Henrich recently assumed his new positions as the dean of the University of Texas Health Science Center at San Antonio (UTHSCSA) Medical School and vice president for medical affairs. UTHSCSA President Francisco G. Cigarroa, MD, described Dr. Henrich as a “fine physician, educator, clinician, researcher and leader of academic medicine” and added that Dr. Henrich will be an excellent addition to UTHSCSA. Dr. Henrich earned his undergraduate degree from Columbia University. He received his medical degree from Baylor College of Medicine in Houston and completed postdoctoral training at the University of Oregon Medical School Hospital and Clinics and the University of Colorado Medical School. He is a former professor and chairman of the Department of Medicine at the Medical College of Ohio and chief of the Medical Service, Medical College Hospital, in Toledo, Ohio. Before joining the UTHSCSA, Dr. Henrich served as Theodore E. Woodward Professor of Medicine and chairman of the Department of Medicine at the University of Maryland School of Medicine in Baltimore, as well as physician-in-chief at the University of Maryland Hospital. Dr. Henrich has long-established links with the state of Texas from earlier stages of his career, particularly as a professor of internal medicine at the University of Texas Southwestern Medical School in Dallas. Additionally, Dr. Henrich served as associate chief of staff for research and development at the VA Medical Center in Dallas and attending physician at Zale Lipshy University Hospital. Board certified in nephrology, Dr. Henrich is president-elect of the American Society of Nephrology and has served on the editorial board of the American Journal of Kidney Diseases. Dr. Henrich is the author of some 200 original articles, chapters, and reviews, as well as the editor of a textbook on dialysis, The Principles and Practice of Dialysis. Dr. Henrich, a diplomate of the American Board of Internal Medicine, has received numerous awards for his research in nephrology and his excellence as a teacher and leader of the medical profession. Dr. Henrich assumed his duties at UTHSCSA in March of 2006.
M. Roy Wilson, MD, Named New Chancellor of the University of Colorado's Denver and Health Sciences Center
Dr. M. Roy Wilson was recently named the new chancellor of the University of Colorado's Denver and Health Sciences Center (UCDHSC), approved by a unanimous vote of the University's Board of Regents. Dr. Wilson will succeed former UCDHSC Chancellor James Shore, who served as chancellor for 7 years before his retirement late in 2005. Dr. Gregory Steigmann served as chancellor on an interim basis prior to Dr. Wilson's appointment. Since 2003, Dr. Wilson has served as president of the four-campus Texas Tech University Health Sciences Center. In his new position, Dr. Wilson will oversee three campuses, with a total of more than 28,000 students and 8,118 employees, spanning a variety of disciplines across the Denver campus and the Health Sciences Center. University of Colorado President Hank Brown said that Dr. Wilson's experience as president of the Texas Tech Health Sciences Center will aid him in the integration and management of the two distinct UCDHSC campuses. Dr. Wilson earned his medical degree from Harvard University Medical School and received his master of science in epidemiology at the University of California at Los Angeles (UCLA) School of Public Health. Dr. Wilson completed his ophthalmology residency and glaucoma fellowship at the Massachusetts Eye and Ear Infirmary at Harvard. Dr. Wilson served as professor of ophthalmology at UCLA's Jules Stein Eye Institute and Charles R. Drew University of Medicine and Science. From 1999 to 2003, Dr. Wilson served as dean and vice president for health sciences at Creighton University School of Medicine. Dr. Wilson was appointed president of Texas Tech University Health Sciences Center in 2003. Also in 2003, Dr. Wilson was inducted into the Institute of Medicine of the National Academy of Sciences. He has published over 200 articles, book chapters, and abstracts, as well as delivered more than 200 invited lectures in the United States and internationally. Dr. Wilson will assume his duties July 1, 2006, as part of a 5-year contract.
Dr. Stavros C. Manolagas Named Dr. Thomas E. Andreoli Clinical Scholar Chair in Internal Medicine
Dr. Stavros C. Manolagas was recently named the inaugural Dr. Thomas E. Andreoli Clinical Scholar Chair in Internal Medicine at the University of Arkansas for Medical Sciences (UAMS) at Little Rock. Dr. Manolagas is professor of internal medicine and director of the Division of Endocrinology and Metabolism at UAMS. Dr. Manolagas also serves as the director of the Center for Osteoporosis and Metabolic Bone Disease, vice chairman for research in the UAMS Department of Internal Medicine, and chief of the Endocrinology Section at the Central Arkansas Veterans Healthcare System.Dr. Manolagas earned his medical degree from the University of Athens in 1969, and in 1979, he completed a research fellowship in biochemistry and endocrinology at the University of Manchester, Manchester Royal Infirmary, in England. Dr. Manolagas was recruited to UAMS in 1993. Under Dr. Manolagas's tutelage, the faculty of the UAMS Division of Endocrinology and Metabolism has grown from 5 to 31 and the budget has grown from $50,000 to more than $5.8 million. Additionally, with nearly $50 million in funding, the Osteoporosis Center has become one of the largest research units in the United States. Dr. Thomas E. Andreoli is a professor in the Department of Internal Medicine and Department of Physiology and Biophysics in the UAMS College of Medicine. The Dr. Thomas E. Andreoli Clinical Scholar Chair was founded in 2005 with donations from various friends and colleagues of Dr. Andreoli.